NIGMS, NIH Grant Qrono $256k Grant for Improvement of AMD Treatment

The National Institute of General Medicine Sciences, National Institute of Health have granted Qrono, a Pittsburgh-based pharmaceutical company, a $256,000 Small Business Technology Transfer Phase I grant for the improvement of wet age-related macular degeneration treatments.

Advertisement

The grant will also help fund the company’s work on long-acting injectable drug formulations.

The grant-funded research will be done in collaboration with The Little Lab of the Swanson School of Engineering at the University of Pittsburgh.

More Articles on Ophthalmology:
$600k Grant to Fund Telemedicine at Flaum Eye Institute
12 Statistics on Ophthalmologist Compensation by Setting
BIOLASE Earns US Patent for Laser Technologies

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Ophthalmology

Advertisement

Comments are closed.